20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

The bad feelings last for a day and the $5 billion last forever. I worry this is the next final act. At some point, NVIDIA puts will be a great buy, because every semiconductor cycle for the last 40 years has ended up in a massive downswing. I ain't buying them today. Most of the time we sit around here waiting, reading and thinking.

And I thought, mmm, that's a real investor. Sass is not dead, and now SAS has an army. I love it. This is 20 VC with me, Harry Sebings, and it's my favorite show of the week. Roryo Driscoll, Jason Lemkin analyzing the biggest news in tech.

This week, anthropics inference costs skyrocket Brax's $5.15 billion deal with Capital One analysed. And the $12 billion priced open evidence round, who wins and who loses in this tech market, all to come in today's episode. But before we dive into the show today, are you a founder working non-stop to raise your next round? Are you an investor doing all you can for your portfolio companies to help them stand out? Funding and scaling a vision is challenging.

We already have this episode, so unlocking it is cheap and permanent: the full transcript (76 minutes, 16,133 words), segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.

No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.